🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the mucolytic activity of Tacholiq...
Status
Completed
Location
Medaimun GmbH
Start Date
2014-08
Trial ID
NCT02515799
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
In 2020, 11.6% of newborns are delivered prematurely in Taiwan. Excessive s...
Status
Completed
Location
Taiwan
Start Date
2023-07-02
Trial ID
NCT07187232
Treatments Being Tested
A clinical study to determine the safety, efficacy and the way sitagliptin ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-14
Trial ID
NCT00704132
Treatments Being Tested
The purpose of this study is to determine the relative abuse potential of r...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00671632
Treatments Being Tested
This is a dose-ranging study designed to investigate the efficacy and safet...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-12
Trial ID
NCT01490632
Treatments Being Tested
This is a phase one study to assess the safety of daily dosing of Lactobaci...
Status
Completed
Location
Community of Santa Clara
Start Date
2010-02
Trial ID
NCT00774163
Treatments Being Tested
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested